Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma

被引：3
|
作者：
Krishnan, Jerry A. [1 ]
Au, David H. [2 ,3 ]
机构：
[1] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, 1220 S Wood St,MC 619, Chicago, IL 60608 USA
[2] Vet Affairs Puget Sound Hlth Care Syst, Ctr Innovat Vet Ctr & Value Driven Care, Hlth Serv Res & Dev Serv, Seattle, WA USA
[3] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 319卷 / 14期
关键词：
D O I：
10.1001/jama.2018.2029
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1441 / 1443
页数：3
相关论文
共 44 条
  • [41] Tolerability profiles of leukotriene receptor antagonists and long-acting β2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma:: A review
    Colucci, R.
    Fornai, M.
    Tuccori, M.
    Antonioli, L.
    Pasqualetti, G.
    Blandizzi, C.
    Del Tacca, M.
    JOURNAL OF ASTHMA, 2007, 44 (06) : 411 - 422
  • [42] SHORT-ACTING AND LONG-ACTING β2-AGONISTS UPREGULATE ASTHMA-RELEVANT PRO-INFLAMMATORY MEDIATORS IN HUMAN AIRWAY EPITHELIAL CELLS WHILE SHORT-ACTING MUSCARINIC ANTAGONISTS DO NOT
    Kumar, K.
    Losa, F.
    Kebadze, T.
    Singanayagam, A.
    Edwards, M. R.
    Johnston, S. L.
    THORAX, 2019, 74 : A88 - A88
  • [43] COST-EFFECTIVENESS ANALYSIS OF TWO LONG-ACTING MUSCARINIC ANTAGONISTS FOR COPD TREATMENT IN SPAIN: UMECLIDINIUM VS. TIOTROPIUM (HO-17-18472)
    Huerta, A.
    Vallejo-Aparicio, L. A.
    VALUE IN HEALTH, 2017, 20 (09) : A646 - A646
  • [44] The 24-Hour Profile of FEV1 After 12-Weeks Treatment With Revefenacin, a Once Daily Long-Acting Muscarinic Receptor Antagonists for Nebulization: A Spirometry Substudy
    Donohue, James
    Pendyala, Srikanth
    Barnes, Chris
    Moran, Edmund
    Crater, Glenn
    CHEST, 2017, 152 (04) : 770A - 770A
12345